foxo4-dri peptide senolytic mouse study 2023 2024

foxo4-dri peptide senolytic mouse study 2023 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI UK | Senolytic Peptide

Name: foxo4-dri peptide senolytic mouse study 2023 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI UK | Senolytic Peptide
Brand: uqtrucking.com
SKU: 6717436011
Price: 21.64 USD
Availability: InStock
Rating: 4.1926 (8 reviews)

FOXO4 DRI UK Senolytic Peptide Research Peptides Lab UK The costs and benefits of senotherapeutics for human health The Lancet Healthy Longevity Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology FOXO4 DRI improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from Leydig cells ScienceDirect

SKU: 6717436011 · From uqtrucking.com

4.2

USD21.64 USD43.64

Pay in 4 interest-free payments of $5.41 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

Description

Complementary DNA (cDNA) was made by reverse transcription of RNA (2 g) using Moloney murine leukemia virus reverse transcriptase (Promega, Madison, MI, USA) and labeled with Biotin-16-2-deoxy-uridine-5-triphosphate (Roche Diagnostics, Indianapolis, IN, USA)

7.3.2 Functional validation of epigenetic modifications 7.3.2.1 CRISPR-based epigenetic editing CRISPR/dCas9-mediated epigenetic editing provides powerful tools to reverse or confirm EED-induced DNA methylation changes (143)

Curr Pharm Des 19: 7683

Its short peptide structure allows researchers to work with clearly defined molecular compositions, improving experimental reproducibility and analytical accuracy